Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H21N |
Molecular Weight | 251.366 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCC(NC1)C(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=RWTNXJXZVGHMGI-UHFFFAOYSA-N
InChI=1S/C18H21N/c1-3-9-15(10-4-1)18(16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17-19H,7-8,13-14H2
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL238 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23261499 |
32.0 nM [Ki] | ||
Target ID: CHEMBL222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23261499 |
213.0 nM [Ki] |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Desoxypipradrol
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
49UNK1BV8T
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY | |||
|
208-276-6
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY | |||
|
DTXSID90897502
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY | |||
|
519-74-4
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY | |||
|
8015
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY | |||
|
160506
Created by
admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD